Published in Vasc Med on January 01, 2000
Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol (2013) 2.79
Pulse wave analysis. Br J Clin Pharmacol (2001) 2.33
Mechanisms underlying elevated SBP differ with adiposity in young adults: the Enigma study. J Hypertens (2016) 1.40
Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey. J Hypertens (2010) 1.23
Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clin Proc (2010) 1.14
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag (2011) 1.02
Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart (2005) 0.99
I Luso-Brazilian Positioning on Central Arterial Pressure. Arq Bras Cardiol (2017) 0.75
Predictors of high central blood pressure in young with isolated systolic hypertension. Vasc Health Risk Manag (2016) 0.75
Pulsatile and Steady-State Pressure Trends in Children: Is the Future Now?: Comment on the Paper by Zachariah and Kovacikova [Pulse 2014;2:57-62]. Pulse (Basel) (2015) 0.75
An assessment of health hazard/health risk appraisal. Am J Public Health (1982) 3.12
The history of commonly used dental elevators. Br Dent J (2008) 2.57
Prazosin: the first-dose phenomenon. Br Med J (1976) 2.51
Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50
Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature (1999) 2.24
Left handed GDP's and students. Br Dent J (1995) 2.01
Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmacol (1991) 1.87
Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem (2001) 1.86
Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J Biol Chem (1992) 1.82
Unfavorable effects of passive smoking on aortic function in men. Ann Intern Med (1998) 1.67
Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol (1989) 1.67
Experience with prazosin in the treatment of patients with severe hypertension. Med J Aust (1976) 1.62
Drug therapy. Prazosin. N Engl J Med (1979) 1.62
Exaggerated physiologic speckled mottling of the limbs. Arch Dermatol (1985) 1.53
Cancer of endometrium and prolonged estrogen therapy. J Am Med Assoc (1946) 1.50
The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. J Biol Chem (1994) 1.49
Autologous vein graft-coated stent for treatment of coronary artery disease. Cathet Cardiovasc Diagn (1996) 1.48
More supernumeraries? Br Dent J (1997) 1.39
Total reconstruction of a diseased saphenous vein graft by means of conventional and autologous tissue-coated stents. Cathet Cardiovasc Diagn (1998) 1.38
The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science (1984) 1.32
Alpha blocking action of the antihypertensive agent, prazosin. J Pharmacol Exp Ther (1977) 1.28
Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res (2001) 1.28
The effect of mental arithmetic in normotensive and hypertensive subjects, and its modification by beta-adrenergic receptor blockade. Br J Clin Pharmacol (1977) 1.27
Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract (2010) 1.23
Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail. Proc Natl Acad Sci U S A (1998) 1.22
Non-alpha-helical elements modulate polytopic membrane protein architecture. J Mol Biol (2001) 1.21
Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol (1996) 1.21
Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J Biol Chem (1995) 1.20
Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol (1998) 1.20
Cardiovascular responses to exercise as functions of absolute and relative work load. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.20
The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Biochemistry (1997) 1.18
Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations. J Pharmacol Exp Ther (1981) 1.15
Genomic organization and expression of the human alpha 1B-adrenergic receptor. J Biol Chem (1992) 1.14
Cloning of the gene and cDNA for human heart chymase. J Biol Chem (1991) 1.13
Influence of dosage and dietary sodium on the first-dose effects of prazosin. Br Med J (1977) 1.10
Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science (1985) 1.10
Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol (1983) 1.10
Phorbol esters inhibit alpha 1-adrenergic effects and decrease the affinity of liver cell alpha 1-adrenergic receptors for (-)-epinephrine. J Biol Chem (1986) 1.09
Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem. Circulation (1997) 1.09
Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter. Circulation (1995) 1.08
Juvenile plantar dermatosis. Clin Exp Dermatol (1987) 1.07
Release of the neuregulin functional polypeptide requires its cytoplasmic tail. J Biol Chem (1998) 1.07
Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation (1999) 1.06
GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem (2000) 1.06
Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation (1995) 1.05
Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Mol Pharmacol (1994) 1.05
Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. J Biol Chem (1989) 1.04
Role of muscle mass and mode of contraction in circulatory responses to exercise. J Appl Physiol (1985) (1985) 1.04
Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation (1997) 1.04
Intracellular mediators of c-fos induction. Cold Spring Harb Symp Quant Biol (1988) 1.01
Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther (2005) 1.01
Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension. Clin Pharmacol Ther (1979) 1.00
Coupling of expressed alpha 1B- and alpha 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific. Mol Pharmacol (1993) 1.00
Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest (1979) 1.00
Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet (1982) 1.00
Renal function during long-term treatment of hypertension with minoxidil: comparison of benign and malignant hypertension. Ann Intern Med (1980) 0.99
A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. II. Purification, characterization, and reconstitution. J Biol Chem (1990) 0.99
Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem (1996) 0.99
Autosomal dominant junctional epidermolysis bullosa. Br J Dermatol (2009) 0.99
Pathogenesis of inherited forms of dilated cardiomyopathy. N Engl J Med (1999) 0.98
Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model. Biochem J (1999) 0.97
A novel putative protein-tyrosine phosphatase contains a BRO1-like domain and suppresses Ha-ras-mediated transformation. J Biol Chem (1998) 0.97
Placental transmission of cephaloridine. J Obstet Gynaecol Br Commonw (1967) 0.96
Epithelial markers in primary skin cancer: an immunoperoxidase study of the distribution of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in 65 primary skin carcinomas. Histopathology (1984) 0.95
Outcomes of trauma patients who survive prolonged lengths of stay in the intensive care unit. J Trauma (2000) 0.95
Percutaneous iontophoresis of prednisolone--a pharmacokinetic study. Clin Exp Dermatol (1986) 0.95
Effects of balloon mitral valvuloplasty on left atrial function in mitral stenosis as assessed by pressure-area relation. J Am Coll Cardiol (1998) 0.94
A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. I. Identification by photolabeling or membrane and ternary complex preparation. J Biol Chem (1990) 0.94
Molecular characterization of adrenergic receptors. Circ Res (1985) 0.93
Serum-mediated enhancement of ANF accumulation in the culture medium of cardiac atriocytes. Biochem Biophys Res Commun (1986) 0.93
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol (2006) 0.93
Assessment of left atrial pressure-area relation in humans by means of retrograde left atrial catheterization and echocardiographic automatic boundary detection: effects of dobutamine. J Am Coll Cardiol (1998) 0.93
Evolutionary conservation of both the hydrophilic and hydrophobic nature of transmembrane residues. J Theor Biol (1995) 0.92
Effects of ventricular pacing-induced tachycardia on aortic mechanics in man. Cardiovasc Res (1998) 0.92
Mast cells and cancer of the cervix. Surg Gynecol Obstet (1966) 0.91
Glycosylation of the mammalian alpha 1-adrenergic receptor by complex type N-linked oligosaccharides. Mol Pharmacol (1987) 0.89
Production, characterization, and expression of neuropeptide Y by human pheochromocytoma. J Clin Invest (1995) 0.89
NADP improves the efficiency of cholera toxin catalyzed ADP-ribosylation in liver and heart membranes. Biochem Biophys Res Commun (1986) 0.89
Normothermic ex vivo perfusion provides superior organ preservation and enables viability assessment of hearts from DCD donors. Am J Transplant (2015) 0.89
Identification of structurally distinct alpha 2-adrenergic receptors. J Biol Chem (1988) 0.88
Similarity of the hemodynamic responses to static and dynamic exercise of small muscle groups. Circ Res (1981) 0.88
Pharmacological evidence for a functional role of the prejunctional alpha-adrenoreceptor in noradrenergic neurotransmission in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.88
Chimeras of alpha1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization. J Biol Chem (1996) 0.88
Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation. EMBO J (2000) 0.87
Transient high-affinity binding of agonists to alpha 1-adrenergic receptors of intact liver cells. FEBS Lett (1985) 0.87
Phe310 in transmembrane VI of the alpha1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding. J Biol Chem (1999) 0.87
Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. J Vasc Surg (1999) 0.87
Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband. J Invest Dermatol (1998) 0.87
Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents. Am J Cardiol (1984) 0.87
Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding. J Biol Chem (1995) 0.86
Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes. J Mol Cell Cardiol (2006) 0.86
Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience (2013) 0.86
Further Studies on the Cytologic Method in the Problem of Gastric Cancer. Ann Surg (1948) 0.86
Intercellular canaliculi in eccrine sweat glands: an immunoperoxidase study. Br J Dermatol (1985) 0.85
Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture. Mol Pharmacol (1985) 0.85
Stents wrapped in autologous vein: an experimental study. J Am Coll Cardiol (1996) 0.84
Near fatal drug interactions with methotrexate given for psoriasis. Br Med J (Clin Res Ed) (1987) 0.84
Effects of prazosin and phentolamine on arterial pressure, heart rate, and renin activity: evidence in the conscious rat for the functional significance of the presynaptic alpha-receptor. J Cardiovasc Pharmacol (1980) 0.84
Considerations in the long-term treatment of hypertension. Clin Ther (1983) 0.84
Retrograde nontransseptal balloon mitral valvuloplasty using a modified Inoue balloon catheter. Cathet Cardiovasc Diagn (1994) 0.84